1. Home
  2. NRXP vs LIVE Comparison

NRXP vs LIVE Comparison

Compare NRXP & LIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • LIVE
  • Stock Information
  • Founded
  • NRXP 2015
  • LIVE 1968
  • Country
  • NRXP United States
  • LIVE United States
  • Employees
  • NRXP N/A
  • LIVE N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • LIVE Other Specialty Stores
  • Sector
  • NRXP Health Care
  • LIVE Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • LIVE Nasdaq
  • Market Cap
  • NRXP 32.6M
  • LIVE 26.6M
  • IPO Year
  • NRXP N/A
  • LIVE N/A
  • Fundamental
  • Price
  • NRXP $3.50
  • LIVE $15.70
  • Analyst Decision
  • NRXP Strong Buy
  • LIVE
  • Analyst Count
  • NRXP 4
  • LIVE 0
  • Target Price
  • NRXP $28.50
  • LIVE N/A
  • AVG Volume (30 Days)
  • NRXP 295.0K
  • LIVE 173.4K
  • Earning Date
  • NRXP 08-13-2025
  • LIVE 08-07-2025
  • Dividend Yield
  • NRXP N/A
  • LIVE N/A
  • EPS Growth
  • NRXP N/A
  • LIVE N/A
  • EPS
  • NRXP N/A
  • LIVE N/A
  • Revenue
  • NRXP N/A
  • LIVE $455,142,000.00
  • Revenue This Year
  • NRXP N/A
  • LIVE N/A
  • Revenue Next Year
  • NRXP N/A
  • LIVE N/A
  • P/E Ratio
  • NRXP N/A
  • LIVE N/A
  • Revenue Growth
  • NRXP N/A
  • LIVE 5.53
  • 52 Week Low
  • NRXP $1.10
  • LIVE $6.25
  • 52 Week High
  • NRXP $6.01
  • LIVE $25.88
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 66.15
  • LIVE 54.59
  • Support Level
  • NRXP $2.90
  • LIVE $7.01
  • Resistance Level
  • NRXP $3.61
  • LIVE $14.35
  • Average True Range (ATR)
  • NRXP 0.28
  • LIVE 2.93
  • MACD
  • NRXP -0.03
  • LIVE -0.19
  • Stochastic Oscillator
  • NRXP 64.59
  • LIVE 50.70

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

Share on Social Networks: